PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxazolidine 9 2 0.22 -0.78 0.22 0.92
BAFF 1,240 Target Target CD254 9 2 0.02 -0.88 0.22 0.72
Cancer 1,053,491 Disease Target CXCL4/PF4 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target CD254 9 2 0.00 -0.88 0.22 0.55
Prostate Cancer 71,064 Disease Drug Doxoform 9 2 0.00 -0.88 0.22 0.61
CCL2 3,560 Target Target CXCL4/PF4 9 2 0.01 -0.88 0.22 0.68
CXCL9 1,016 Target Target CXCL4/PF4 9 2 0.02 -0.88 0.22 0.72
Doxoform 9 Drug Drug Doxazolidine 9 2 0.22 -0.78 0.22 0.92
CD68 6,424 Target Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.65
Colon Cancer 30,064 Disease Drug Doxorubicin-Formaldehyde Conjugate 9 1 0.00 -0.94 0.11 0.61
Colon Cancer 30,064 Disease Drug Doxoform 9 1 0.00 -0.94 0.11 0.61
Diabetes 332,602 Disease Drug Aprotinin (Trasylol)- FDA 9 1 0.00 -0.94 0.11 0.56
Diabetes 332,602 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.56
CCL19 658 Target Target CXCL4/PF4 9 1 0.01 -0.94 0.11 0.71
Obesity 138,233 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.58
Carcinoma 433,099 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.56
Carcinoma 433,099 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.56
Hemorrhage 100,979 Disease Drug Aprotinin (Trasylol)- FDA 9 1 0.00 -0.94 0.11 0.58
CXCL7 76 Target Target CXCL4/PF4 9 1 0.04 -0.94 0.11 0.79
BLyS 457 Target Target CD254 9 1 0.02 -0.94 0.11 0.73
CCL4 5,638 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.65
Prostate Cancer 71,064 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.59
Tuberculosis 146,217 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.58
Skin Cancer 11,561 Disease Target CD254 9 1 0.00 -0.94 0.11 0.63
Infection 766,637 Disease Target CINC-2- alpha 9 1 0.00 -0.94 0.11 0.54
Infection 766,637 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.54
Glaucoma 41,465 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.60
Cathepsin G 1,613 Target Target CINC-2- alpha 9 1 0.01 -0.94 0.11 0.69
Stroke 146,992 Disease Drug Aprotinin (Trasylol)- FDA 9 1 0.00 -0.94 0.11 0.58
Glomerulonephritis 23,459 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.62
Arthritis 128,324 Disease Target CD254 9 1 0.00 -0.94 0.11 0.58
CD154 1,512 Target Target CD254 9 1 0.01 -0.94 0.11 0.69
Sarcoidosis 19,176 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.62
Rheumatoid Arthritis 78,952 Disease Target CD254 9 1 0.00 -0.94 0.11 0.59
Retinitis 9,116 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.64
Collagen 138,882 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.58
CD95 4,266 Target Target CD254 9 1 0.01 -0.94 0.11 0.66
Cox-2 21,583 Target Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.62
CD137 474 Target Target CD254 9 1 0.02 -0.94 0.11 0.72
Leukemia 162,805 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.57
Endoglin 1,333 Target Target CD254 9 1 0.01 -0.94 0.11 0.69
Breast Cancer 173,695 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.57
bFGF 9,327 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.64
CCL8 197 Target Target CXCL4/PF4 9 1 0.02 -0.94 0.11 0.75
Inflammation 252,734 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.57
Exodus-2 27 Target Target Exodus-3 8 7 0.48 -0.30 0.88 0.92
Cancer 1,053,491 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 6 0.00 -0.50 0.75 0.58
ELC 355 Target Target Exodus-3 8 5 0.09 -0.61 0.62 0.79
Cancer 1,053,491 Disease Target Prostaglandin Reductase 1 8 4 0.00 -0.71 0.50 0.57
Prostate Cancer 71,064 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 4 0.01 -0.71 0.50 0.63
BNP 6,842 Target Target Brain (B-type) Natriuretic Protein 8 4 0.02 -0.71 0.50 0.69
Androgen Receptor 12,918 Target Target Aldo-Keto Reductase Family 1 Member C3 8 3 0.01 -0.79 0.38 0.66
CD4 112,219 Target Target Exodus-3 8 3 0.00 -0.79 0.38 0.61
Cancer 1,053,491 Disease Drug Dromostanolone 8 3 0.00 -0.79 0.38 0.56
Dromostanolone Propionate 3 Drug Drug Dromostanolone 8 3 0.61 -0.41 1.00 0.95
Colon Cancer 30,064 Disease Target Prostaglandin Reductase 1 8 2 0.00 -0.87 0.25 0.63
Aldactone (Spironolactone)- FDA 18 Drug Drug Alprazolam (Xanax)- FDA 8 2 0.17 -0.82 0.25 0.88
Carcinoma 433,099 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 2 0.00 -0.87 0.25 0.57
Stroke 146,992 Disease Drug Doxaminol 8 2 0.00 -0.87 0.25 0.59
Shock 134,031 Disease Target Glutathione S-Transferase Mu 2 8 2 0.00 -0.87 0.25 0.60
Anemia 81,663 Disease Drug Dromostanolone 8 2 0.00 -0.87 0.25 0.61
Lung Cancer 91,416 Disease Target CD62L/L-Selectin 8 1 0.00 -0.94 0.12 0.59
Seizure 44,685 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.60
Diabetes 332,602 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.56
Diabetes 332,602 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.56
CCL19 658 Target Target Exodus-3 8 1 0.01 -0.93 0.12 0.72
Poisoning 53,779 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.60
Obesity 138,233 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.58
Carcinoma 433,099 Disease Drug Dromostanolone 8 1 0.00 -0.94 0.12 0.56
Carcinoma 433,099 Disease Target Prostaglandin Reductase 1 8 1 0.00 -0.94 0.12 0.56
Cervical Cancer 28,286 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 1 0.00 -0.94 0.12 0.61
Depression 220,092 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.57
Cancer 1,053,491 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.54
Fracture 111,575 Disease Disease Deficiency Vitamin D 8 1 0.00 -0.94 0.12 0.58
Ck-beta-11 4 Target Target Exodus-3 8 1 0.18 -0.81 0.25 0.89
Hypertriglyceridemia 7,877 Disease Drug Dromostanolone 8 1 0.00 -0.94 0.12 0.65
Tuberculosis 146,217 Disease Target Prostaglandin Reductase 1 8 1 0.00 -0.94 0.12 0.58
Infection 766,637 Disease Target Prostaglandin Reductase 1 8 1 0.00 -0.94 0.12 0.55
Kidney Diseases 4,651 Disease Target Glutathione S-Transferase Mu 2 8 1 0.01 -0.94 0.12 0.66
AKT3 293 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.74
Lung Carcinoma 13,423 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 1 0.00 -0.94 0.12 0.63
Glomerulonephritis 23,459 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.62
Shock 134,031 Disease Target Prostaglandin Reductase 1 8 1 0.00 -0.94 0.12 0.58
Benign Prostatic Hyperplasia 10,026 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 1 0.00 -0.94 0.12 0.64
Annexin A1 406 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.73
Major Depressive Disorder 12,517 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.63
CCL2 3,560 Target Target Glutathione S-Transferase Mu 2 8 1 0.01 -0.94 0.12 0.67
Antithrombin 13,773 Target Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.63
Acute Coronary Syndromes 9,133 Disease Target Brain (B-type) Natriuretic Protein 8 1 0.00 -0.94 0.12 0.64
Glutaredoxin-1 142 Target Target Glutathione S-Transferase Mu 2 8 1 0.03 -0.93 0.12 0.77
Collagen 138,882 Target Target Brain (B-type) Natriuretic Protein 8 1 0.00 -0.94 0.12 0.58
Cardiac Arrest 20,700 Disease Drug Doxaminol 8 1 0.00 -0.94 0.12 0.62
Avandia (Rosiglitazone Maleate)- FDA 66 Drug Drug Alprazolam (Xanax)- FDA 8 1 0.04 -0.93 0.12 0.80
Leukemia 162,805 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.58
Breast Cancer 173,695 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.58
Breast Cancer 173,695 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.58
Proteinuria 28,803 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.61
CD34 24,598 Target Target Exodus-3 8 1 0.00 -0.94 0.12 0.62
Inflammation 252,734 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.57